We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Justices Urged To Ax Fed. Circ. Drug Patent Obviousness Test

Law360 (October 11, 2018, 8:59 PM EDT) -- Accord Healthcare Inc. has told the U.S. Supreme Court that a Federal Circuit decision upholding UCB Inc.'s patent on an epilepsy drug found that the patent is not obvious by using...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Supreme Court

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

October 9, 2018

Law Firms

Companies

Government Agencies

Patents

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.